PTPRC and lung cancer: Additionally, splenic erythroid progenitors (CD45+CD71+Ter119+) confer potent immunosuppressive effects in mice with lung cancer by inhibiting CD8+ T cells (22) or by transdifferentiating into erythroid-derived myeloid cells (23).